Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients31
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection27
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective20
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting17
The making of the one pill—Developing single tablet regimens for HIV and for HCV15
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts14
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation14
Cost-effectiveness of tenofovir alafenamide fumarate for treatment of chronic hepatitis B: Evidence from a tertiary hospital in Vietnam13
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants13
Commentary: John C. Martin (1951–2021)10
A rare complication of coronary vasospasm associated with concomitant use of ergotamine, cobicistat, and darunavir10
Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study10
0.170658826828